KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBITDA: 2009-2014

Historic EBITDA for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$45.3 million.

  • Biocryst Pharmaceuticals' EBITDA fell 66.40% to -$14.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$36.6 million, marking a year-over-year increase of 6.13%. This contributed to the annual value of -$45.3 million for FY2014, which is 50.42% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported EBITDA of -$45.3 million as of FY2014, which was down 50.42% from -$30.1 million recorded in FY2013.
  • Biocryst Pharmaceuticals' EBITDA's 5-year high stood at -$30.1 million during FY2013, with a 5-year trough of -$57.0 million in FY2011.
  • Over the past 3 years, Biocryst Pharmaceuticals' median EBITDA value was -$39.1 million (recorded in 2012), while the average stood at -$38.2 million.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' EBITDA plummeted by 150.11% in 2010, and later surged by 31.43% in 2012.
  • Over the past 5 years, Biocryst Pharmaceuticals' EBITDA (Yearly) stood at -$34.4 million in 2010, then tumbled by 65.94% to -$57.0 million in 2011, then spiked by 31.43% to -$39.1 million in 2012, then rose by 22.93% to -$30.1 million in 2013, then tumbled by 50.42% to -$45.3 million in 2014.